Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Fri, September 22, 2023
Thu, September 21, 2023

Graig Suvannavejh Reiterated (AXSM) at Strong Buy and Held Target at $100 on, Sep 25th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-100-on-sep-25th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Graig Suvannavejh of Mizuho, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $100 on, Sep 25th, 2023.

Graig has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 2 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $81 on, Tuesday, August 8th, 2023
  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023


These are the ratings of the 4 analyists that currently disagree with Graig


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $108 on, Tuesday, August 22nd, 2023
  • David Amsellem of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $90 on, Tuesday, August 8th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $180 on, Tuesday, August 8th, 2023
  • Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Thursday, June 15th, 2023

Publication Contributing Sources